Shareholding disclosure

Yves Sagot

Declared position

3.382%

Threshold

Crossed upwards

Timeline

Published

26.01.2021

Transaction

20.01.2021

Transfer date

20.01.2021

Voting rights breakdown

Voting rights acquired3.382%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAL1M00085

Beneficial owner

Yves Sagot

Declared address

Yves Sagot

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Yves Sagot

MindMaze Therapeutics Holding SA26.01.2021TAL1M00085

Disclosure summary

Yves Sagot disclosed a holding in MindMaze Therapeutics Holding SA on the acquisition side, published by SIX Exchange Regulation on 26.01.2021, at 3.382% of voting rights. Notice category: Single shareholder.

Disclosed position

3.382%

Voting rights acquired

Voting rights acquired3.382%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Yves Sagot disclosed a holding in MindMaze Therapeutics Holding SA, published on 26.01.2021.

Publication date26.01.2021

Transaction date20.01.2021

Transfer date20.01.2021

Issuing companyMindMaze Therapeutics Holding SA

Beneficial ownerYves Sagot

Declared addressYves Sagot

CategorySingle shareholder

Voting rights acquired3.382%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAL1M00085

Source: SIX Exchange Regulation · Publication date: 26.01.2021

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open